Professor Samuel Seidu

Professor Sam Seidu is Professor in Primary Care Diabetes and Cardio-metabolic Medicine. He is currently the vice-chair for Research for Primary Care Diabetes Europe (PCDE). He is a board member of the Primary Care Diabetes Society of UK and is also currently a Clinical Lead and mentor for diabetes in the Leicester, Leicestershire and Rutland Integrated Care System. In 2021, he was named the most outstanding early career researcher by the Royal College of General Practitioners. He is an Associate Editor of the Primary Care Diabetes Journal.

• Medication safety in diabetes and cardiometabolic diseases in the elderly population.
• therapeutic inertia in people with diabetes to understand the causes, outcomes, and possible solutions.
• Prevention of Cardiometabolic Diseases.
• Ethnic Minority Health and health inequalities in diabetes care.
• Real World Evidence
• Quality improvement in diabetes care in primary care settings.

https://scholar.google.co.uk/citations?user=bCw_tzoAAAAJ&hl=en&oi=ao

1. Seidu S, Willis H, Kunutsor SK, Khunti K. Intensive versus standard blood pressure control in older persons with or without diabetes: a systematic review and meta-analysis of randomised controlled trials. J R Soc Med. 2023 Feb 24:1410768231156997. doi: 10.1177/01410768231156997. Epub ahead of print. PMID: 36825537.

2. Van Grondelle SE, Van Bruggen S, Rauh SP, Van der Zwan M, Cebrian A, Seidu S, Rutten GEHM, Vos HMM, Numans ME, Vos RC. The impact of the covid-19 pandemic on diabetes care: the perspective of healthcare providers across Europe. Prim Care Diabetes. 2023 Feb 16:S1751-9918(23)00033-5. doi: 10.1016/j.pcd.2023.02.002. Epub ahead of print. PMID: 36822977; PMCID: PMC9933343.
3. Kunutsor SK, Isiozor NM, Myers J, Seidu S, Khunti K, Laukkanen JA. Baseline and usual cardiorespiratory fitness and the risk of chronic kidney disease: A prospective study and meta-analysis of published observational cohort studies. Geroscience. 2023 Jan 17. doi: 10.1007/s11357-023-00727-3. Epub ahead of print. PMID: 36646903.
4. Seidu S, Abdool M, Almaqhawi A, Wilkinson TJ, Kunutsor SK, Khunti K, Yates T. Physical activity and risk of chronic kidney disease: systematic review and meta-analysis of 12 cohort studies involving 1,281,727 participants. Eur J Epidemiol. 2023 Jan 10. doi: 10.1007/s10654-022-00961-7. Epub ahead of print. PMID: 36626101.
5. Highton PJ, Cassambai S, Jessen N, Agot GN, Hadjiconstantinou M, Davies M, Seidu S, Njoroge PK, Olenja JM, Godia P, Damasceno A, Lamptey R, Khunti K. Cardiometabolic disease and multiple long-term condition healthcare provision in Sub-Saharan Africa: Opportunities for new models of care in the post-COVID era. Diabetes Metab Syndr. 2023 Jan;17(1):102681. doi: 10.1016/j.dsx.2022.102681. Epub 2022 Dec 5. PMID: 36521305.
6. Seidu S, Gillies C, Zaccardi F, Reeves K, Gallier S, Khunti K. Temporal trends in admissions for atrial fibrillation and severe bleeding in England: an 18-year longitudinal analysis. Scand Cardiovasc J. 2023 Dec;57(1):40-47. doi: 10.1080/14017431.2022.2156597. PMID: 36519374.
7. Seidu S, Cos X, Topsever P. Self-rated knowledge and competence regarding the management of chronic kidney disease in primary care: A cross-sectional European survey of primary care professionals. Prim Care Diabetes. 2023 Feb;17(1):19-26. doi: 10.1016/j.pcd.2022.11.013. Epub 2022 Dec 10. PMID: 36513582.
8. Khunti K, Aroda VR, Aschner P, Chan JCN, Del Prato S, Hambling CE, Harris S, Lamptey R, McKee M, Tandon N, Valabhji J, Seidu S. The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery. Lancet Diabetes Endocrinol. 2022 Dec;10(12):890-900. doi: 10.1016/S2213-8587(22)00278-9. Epub 2022 Nov 7. PMID: 36356612; PMCID: PMC9640202.
9. Quinn LM, Woolley AK, Davies MJ, Bodicoat DH, Seidu S, Khunti K, Hadjiconstantinou M. Educational preferences in individuals with cardiometabolic disease differs with age, ethnicity and educational status. Patient Educ Couns. 2022 Dec;105(12):3479-3486. doi: 10.1016/j.pec.2022.08.016. Epub 2022 Aug 30. PMID: 36150978
10. Seidu S, Cebrián A, Kunutsor SK, Khunti K. Erectile dysfunction, phosphodiesterase-5 inhibitor use and risk of cardiovascular disease and mortality in people with diabetes: A systematic review and meta-analysis. Prim Care Diabetes. 2022 Oct;16(5):601-613.

1. K Woolley, In-Practice Fellowship 
   Title: Improving Cardiometabolic Health in Early school Leavers
2. S Hickman, PhD 
   Title: De-prescribing in older people with diabetes and cardiometabolic multi-morbidities
3. H Osman, PhD 
   Title: A comparative analysis of a novel biochemical urine screen with pharmacy prescription records and a self- reported questionnaire to assess non-adherence in people with type 2 diabetes mellitus

1. https://diatribe.org/challenging-limits-cgm-elderly-and-those-type-2-diabetes
2. https://drive.google.com/file/d/1XL4LADqxlKwsCLetZGOMVg3QSDDMW_V3/view
3. https://www.bbc.co.uk/sounds/play/m00114cm
4. https://www.diabetes.org.uk/about_us/news/samuel-day-life-clinical-professor
5. https://www.medscape.com/viewarticle/932064
6. https://www.sciencedaily.com/releases/2017/01/170119100233.htm
7. https://www.lovebusinesseastmidlands.com/love-business-news/2019/02/28/leicester-doctors-at-heart-of-new-european-diabetes-guidance
8. https://www.gponline.com/winner-rcgp-research-paper-year-announced/article/1730195